EP3897723A4 - Production d'anticorps monoclonal spécifique du récepteur cellulaire cd24 - Google Patents

Production d'anticorps monoclonal spécifique du récepteur cellulaire cd24 Download PDF

Info

Publication number
EP3897723A4
EP3897723A4 EP20878673.1A EP20878673A EP3897723A4 EP 3897723 A4 EP3897723 A4 EP 3897723A4 EP 20878673 A EP20878673 A EP 20878673A EP 3897723 A4 EP3897723 A4 EP 3897723A4
Authority
EP
European Patent Office
Prior art keywords
production
monoclonal antibody
cell receptor
antibody specific
receptor
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
EP20878673.1A
Other languages
German (de)
English (en)
Other versions
EP3897723A1 (fr
Inventor
Asuman SUNGUROGLU
Hasan Çaglar UGUR
Dilara AKÇORA YILDIZ
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ankara Ueniversitesi Rektoerluegue
Ankara Ueniversitesi Rektoerluegue
Original Assignee
Ankara Ueniversitesi Rektoerluegue
Ankara Ueniversitesi Rektoerluegue
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ankara Ueniversitesi Rektoerluegue, Ankara Ueniversitesi Rektoerluegue filed Critical Ankara Ueniversitesi Rektoerluegue
Publication of EP3897723A1 publication Critical patent/EP3897723A1/fr
Publication of EP3897723A4 publication Critical patent/EP3897723A4/fr
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2896—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against molecules with a "CD"-designation, not provided for elsewhere
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/10—Immunoglobulins specific features characterized by their source of isolation or production
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
    • C07K2317/52—Constant or Fc region; Isotype

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
EP20878673.1A 2019-10-23 2020-10-22 Production d'anticorps monoclonal spécifique du récepteur cellulaire cd24 Pending EP3897723A4 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
TR201916358 2019-10-23
PCT/TR2020/050972 WO2021080541A1 (fr) 2019-10-23 2020-10-22 Production d'anticorps monoclonal spécifique du récepteur cellulaire cd24

Publications (2)

Publication Number Publication Date
EP3897723A1 EP3897723A1 (fr) 2021-10-27
EP3897723A4 true EP3897723A4 (fr) 2022-02-16

Family

ID=75620197

Family Applications (1)

Application Number Title Priority Date Filing Date
EP20878673.1A Pending EP3897723A4 (fr) 2019-10-23 2020-10-22 Production d'anticorps monoclonal spécifique du récepteur cellulaire cd24

Country Status (2)

Country Link
EP (1) EP3897723A4 (fr)
WO (1) WO2021080541A1 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN115947855B (zh) * 2022-05-20 2023-10-27 杭州邦顺制药有限公司 抗cd24抗体的制备及其用途
CN120380019A (zh) * 2022-10-27 2025-07-25 北京星奇原生物科技有限公司 抗cd24抗体及其用途

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009063461A1 (fr) * 2007-11-14 2009-05-22 The Medical Research, Infrastructure, And Health Services Fund Of The Tel Aviv Medical Center Procédés de traitement du cancer à l'aide d'anticorps anti-cd24

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103819561A (zh) * 2014-01-22 2014-05-28 中国药科大学 抗cd24单克隆抗体、其可变区序列及其应用
CN108373504B (zh) * 2017-01-30 2022-06-28 亘喜生物科技（上海）有限公司 Cd24特异性抗体和抗cd24-car-t细胞

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009063461A1 (fr) * 2007-11-14 2009-05-22 The Medical Research, Infrastructure, And Health Services Fund Of The Tel Aviv Medical Center Procédés de traitement du cancer à l'aide d'anticorps anti-cd24

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
ANONYMOUS: "Human CD24 Antibody Monoclonal, Mouse IgG 2B Clone#528807", 7 February 2018 (2018-02-07), pages 1 - 1, XP055876754, Retrieved from the Internet <URL:https://resources.rndsystems.com/pdfs/datasheets/mab5248.pdf?_ga=2.250437318.1556323717.1641540549-2146395444.1636020911> [retrieved on 20220107] *
LEENAARS M. ET AL: "Critical Steps in the Production of Polyclonal and Monoclonal Antibodies: Evaluation and Recommendations", ILAR JOURNAL, vol. 46, no. 3, 1 January 2005 (2005-01-01), US, pages 269 - 279, XP055876792, ISSN: 1084-2020, Retrieved from the Internet <URL:https://watermark.silverchair.com/ilar-46-3-269.pdf?token=AQECAHi208BE49Ooan9kkhW_Ercy7Dm3ZL_9Cf3qfKAc485ysgAAAu0wggLpBgkqhkiG9w0BBwagggLaMIIC1gIBADCCAs8GCSqGSIb3DQEHATAeBglghkgBZQMEAS4wEQQM8CDBznwRm_wLb7CeAgEQgIICoAHlk7d-BV2-mdWuUJUtzC6X2ERMNIdQ4UVkKk10R28hfPy-tHgBuwAb9vV-NQuJKJ9HN-kfoEq7zh3xr1spR0> DOI: 10.1093/ilar.46.3.269 *
See also references of WO2021080541A1 *

Also Published As

Publication number Publication date
WO2021080541A1 (fr) 2021-04-29
EP3897723A1 (fr) 2021-10-27

Similar Documents

Publication Publication Date Title
EP3917952A4 (fr) Anticorps spécifiques à cd44
CL2017001730A1 (es) Anticuerpo anti - alfabeta tcr
EP3743513A4 (fr) Cellules nk-92 modifiées par un récepteur antigénique chimérique
EP3927735A4 (fr) Combinaisons de multiples récepteurs antigéniques chimériques pour l&#39;immunothérapie
IL313679A (en) Novel anti-tslp antibodies
IL285587A (en) Hypoxia-responsive chimeric antigen receptors
DK3628686T3 (da) Humanisering af kanin-antistoffer under anvendelse af et universelt antistof-framework
EP3897723A4 (fr) Production d&#39;anticorps monoclonal spécifique du récepteur cellulaire cd24
EP4211792C0 (fr) Pilier pour suiveurs solaires
NI202000051A (es) Anticuerpos monoclonales y métodos para utilizar los mismos.
DK4214240T3 (da) Anti-ccr8-antistoffer
EP3945848A4 (fr) Probiotiques pour réduire la production de méthane
PL3830132T3 (pl) Humanizowane przeciwciała przeciwko psma
EP4185612A4 (fr) Anticorps anti-abêta
EP4007809A4 (fr) Cellules nk-92 modifiées par un récepteur antigénique chimérique anti-b7-h4
CR20120553A (es) Anticuerpos il-25 humanizados
EP4144370A4 (fr) Anticorps bispécifique
EP3898964A4 (fr) Anticorps spécifiques à muc18
EP4396236A4 (fr) Anticorps anti-il-11r alpha
EP3888678A4 (fr) Préparation d&#39;un anticorps anti-pd-l1
EP4532558A4 (fr) Anticorps anti-ror1
EP4090362A4 (fr) Récepteurs antigéniques chimériques pour éliminer un amyloïde
CO2020004200A2 (es) Anticuerpo monoclonal anti-il-5rα
EP4163301C0 (fr) Anticorps anti-gpc-1 humanisé
IL310901A (en) Compositions and methods for chimeric antigen receptors specific to b cell receptors

Legal Events

Date Code Title Description
STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE

PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE

17P Request for examination filed

Effective date: 20210630

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

REG Reference to a national code

Ref country code: DE

Ref legal event code: R079

Free format text: PREVIOUS MAIN CLASS: A61K0039395000

Ipc: C07K0016280000

A4 Supplementary search report drawn up and despatched

Effective date: 20220118

RIC1 Information provided on ipc code assigned before grant

Ipc: C07K 16/28 20060101AFI20220112BHEP

DAV Request for validation of the european patent (deleted)
DAX Request for extension of the european patent (deleted)
STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: EXAMINATION IS IN PROGRESS

17Q First examination report despatched

Effective date: 20250103